HNRNPAB and metabolic dysfunction-associated steatotic liver disease: The four splicing factors HNRNPAB, PCBP2, A1CF and PABPN1, which were altered in all four NAFLD datasets, also have altered expression in HCC tumors but only HNRNPAB and PCBP2 are associated with survival (Fig. 9D).